Literature DB >> 22989553

When is injury potentially reversible in a lung ischemia-reperfusion model?

Luiz Alberto Forgiarini1, Gustavo Grün, Nélson Alexandre Kretzmann, Gustavo Alfredo Ochs de Muñoz, Antonino de Almeida, Luiz Felipe Forgiarini, Cristiano Feijó Andrade.   

Abstract

OBJECTIVE: To verify the impact of ischemic time on lung cell viability in an experimental model of lung ischemia-reperfusion (IR) injury and its repercussion on lung performance after reperfusion.
METHODS: Twenty-four animals were subjected to selective clamping of the left pulmonary artery and divided into four groups (n = 6) according to ischemic time: 15 (IR15), 30 (IR30), 45 (IR45), and 60 min (IR60). All animals were observed for 120 min after reperfusion. The hemodynamics, arterial blood gases measurements, and histologic changes were analyzed. Immunofluorescence assays for caspase 3 and annexin V were performed. Lipid peroxidation was assessed by thiobarbituric acid-reactive substances, and caspase 3 activity was assessed by colorimetric extract.
RESULTS: The partial pressure of arterial oxygen significantly decreased at the end of the observation period in the IR30, IR45, and IR60 groups (P < 0.05). The final mean arterial pressure significantly decreased in the IR60 group (P < 0.05). We observed a significant increase in caspase 3 activity and caspase 3-positive cells by immunofluorescence in the IR45 group compared with the other groups (P < 0.05). Additionally, there was an increase in necrotic cells assessed by annexin V in the IR60 group. The histologic score did not show differences among the different groups.
CONCLUSIONS: The degree of cell damage had a negative impact on lung performance. Sixty minutes of lung ischemia and posterior reperfusion resulted in an increased number of necrotic cells, suggesting that these cells may not be able to reverse the effects of the IR injury because of the lack of viable cells.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22989553     DOI: 10.1016/j.jss.2012.08.026

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

Review 1.  Oxidative Stress and Lung Ischemia-Reperfusion Injury.

Authors:  Renata Salatti Ferrari; Cristiano Feijó Andrade
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

2.  Endobronchial perfluorocarbon reduces inflammatory activity before and after lung transplantation in an animal experimental model.

Authors:  Luiz Alberto Forgiarini Junior; Arthur Rodrigo Ronconi Holand; Luiz Felipe Forgiarini; Darlan Pase da Rosa; Norma Anair Possa Marroni; Paulo Francisco Guerreiro Cardoso; Cristiano Feijó Andrade
Journal:  Mediators Inflamm       Date:  2013-12-26       Impact factor: 4.711

3.  RC-3095, a selective gastrin-releasing peptide receptor antagonist, does not protect the lungs in an experimental model of lung ischemia-reperfusion injury.

Authors:  Vera L Oliveira-Freitas; Leonardo Dalla Giacomassa Rocha Thomaz; Lucas Elias Lise Simoneti; Christiane Malfitano; Kátia De Angelis; Jane Maria Ulbrich; Gilberto Schwartsmann; Cristiano Feijó Andrade
Journal:  Biomed Res Int       Date:  2015-03-29       Impact factor: 3.411

4.  Does methylene blue attenuate inflammation in nonischemic lungs after lung transplantation?

Authors:  Marcus da Matta Abreu; Francine Maria de Almeida; Kelli Borges Dos Santos; Emílio Augusto Campos Pereira de Assis; Rafael Kenji Fonseca Hamada; Fabio Biscegli Jatene; Paulo Manuel Pêgo-Fernandes; Rogerio Pazetti
Journal:  J Bras Pneumol       Date:  2018 Sep-Oct       Impact factor: 2.624

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.